Your search for

217 results were returned

  1. Legal news
    13 August 2019
    Patents: Declaratory Relief
    www.twobirds.com/en/news/articles/2019/uk/declaratory-relief-arrow-generics-ltd-v-merck-and-co-inc

    The Patents Court has refused to grant an Arrow declaration following de-designation of UK from pending patent applications because there was no uncertainty about UK patent rights and the true purpose of the declaration ...

  2. Legal news
    16 November 2018
    Recomiendan a los laboratorios que se preparen para un ‘Brexit duro’, pese a los avances en Reino Unido
    www.twobirds.com/en/news/articles/2018/spain/181116-recomiendan-a-los-laboratorios-que-se-preparen-para-un-brexit-duro

    Los medios de comunicación de toda Europa amanecían el pasado 14 de noviembre con la noticia sobre el visto bueno del Gobierno británico al principio de acuerdo alcanzado entre Reino Unido y la Comisión Europea, aunque, ...

  3. Legal news
    12 March 2020
    Digital Health 2020
    www.twobirds.com/en/news/articles/2020/global/digital-health-2020

    A practical cross-border insight into digital health law

  4. Legal news
    17 November 2020
    The Finnish Competition and Consumer Authority proposes prohibition of a three-to-two merger in the healthcare sector
    www.twobirds.com/en/news/articles/2020/finland/the-finnish-competition-and-consumer-authority-proposes-prohibition-of-a-three-to-two-merger

    On 29 September 2020, the Finnish Competition and Consumer Authority ("FCCA") proposed the Market Court to prohibit the merger between two national healthcare market players, Mehiläinen and Pihlajalinna. If not ...

  5. Legal news
    19 November 2020
    Business Interruption insurance and COVID-19: the state of play in various jurisdictions
    www.twobirds.com/en/news/articles/2020/global/business-interruption-insurance-and-covid-19-the-state-of-play-in-various-jurisdictions

    Globally, many companies are (again) affected by significant decline in business and/or closures as a result of measures taken by governments to deal with the coronavirus. Many of these companies have some form of ...

  6. Legal news
    04 November 2019
    Are German Courts the “Spoilsport” of the “Divisional Game” when it comes to Preliminary Injunction Requests?
    www.twobirds.com/en/news/articles/2019/germany/are-germany-courts-the-spoilsport-of-the-divisional-game-when-it-comes-to

    If a patentee undertakes actions with respect to a patent of the same patent family (e.g. waiving the parent patent of a divisional patent), this is often negatively characterised as playing the “Divisional Game”. We ...

  7. Legal news
    14 January 2019
    New Decision: Higher Regional Court Düsseldorf on Second Medical Use Patents
    www.twobirds.com/en/news/articles/2019/germany/new-decision-higher-regional-court-dusseldorf-on-second-medical-use-patents

    Almost two years ago, the Higher Regional Court Düsseldorf first iterated new liability criteria with respect to Second Medical Use Patents (cf. decision Östrogenblocker of May 5, 2017, docket no. I-2 W 6/17).

  8. Legal news
    16 August 2019
    Bird & Bird assists AddLife with the acquisition of Lab-Vent Controls and Koldt & Ryø El
    www.twobirds.com/en/news/articles/2019/denmark/bird-bird-radgiver-addlife-med-opkoebet-af-labvent-controls-og-koldt-og-ryoe-el

    Bird & Bird advised AddLife in its acquisition of all shares in the Danish companies Lab-Vent Controls A/S and Koldt & Ryø El A/S.

  9. Legal news
    19 August 2019
    UAE: Healthcare data protection law
    www.twobirds.com/en/news/articles/2019/uae/uae-healthcare-data-protection-law

    In February 2019, the President of the UAE, Khalifa bin Zayed Al Nahyan, issued Federal Law No. 2 of 2019 ('the Law').

  10. Legal news
    02 July 2019
    Transfer of value: amendments to the French “anti-gift” provisions by the draft Health Act
    www.twobirds.com/en/news/articles/2019/global/transfer-of-value-amendments-to-the-french-anti-gift-provisions-by-the-draft-health-act

    The French so-called “anti-gift” provisions strictly frame the conditions under which companies in the health sector are allowed to provide advantages, in cash or in kind, to healthcare professionals ("HCPs”)